Novel preclinical drug could have potential to combat melancholy, brain injury and cognitive disorders
Journal Reference: Alan Umfress, Sarbjit Singh, Kevin J. Ryan, Ayanabha Chakraborti, Florian Plattner, Yogesh Sonawane, Jayapal Reddy Mallareddy, Edward P. Acosta, Amarnath Natarajan, James A. Bibb. Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters Neurobehavior. Frontiers in Pharmacology, 2022; 13 DOI: 10.3389/fphar.2022.863762 Cdk5 is a crucial regulator of signaling in brain neurons. Over three … Read more